Patents by Inventor Lloyd Gary Tillman

Lloyd Gary Tillman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulations
    Patent number: 6730679
    Abstract: Pharmaceutical formulations containing HIV protease inhibitors, specifically including 3S-[3R*(1R*,2S*)]-[3-[[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2-hydroxy-1-phenylmethyl)propyl]carbamic acid, tetrahydro-3-furanyl ester (alternatively known as VX 478 or 141W94), and a tocopherol, and their use in medical therapy are described.
    Type: Grant
    Filed: March 20, 1997
    Date of Patent: May 4, 2004
    Assignee: SmithKline Beecham Corporation
    Inventors: Arup K. Roy, Lloyd Gary Tillman
  • Valaciclovir tablets containing colloidal silicon dioxide
    Patent number: 5879706
    Abstract: A tablet comprising at least 50% w/w valaciclovir and 0.05 to 3% w/w colloidal silicon dioxide in which the valaciclovir is present within granules of the tablets and the silicon dioxide, a lubricant and a microcrystalline cellulose filler are present extragranularly has excellent hardness and friability properties while still maintaining lubrication of the tablet granules.
    Type: Grant
    Filed: August 29, 1997
    Date of Patent: March 9, 1999
    Assignee: Glaxo Wellcome Inc.
    Inventors: Barry Howard Carter, Lloyd Gary Tillman